Herbal Dispatch Brings on Industry Veteran as Strategic Advisor
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leader in cannabis distribution, is pleased to welcome Jay Wilgar, a 20-year veteran in startup management and business growth, to its team as a Strategic Advisor to the management team. Mr. Wilgar is the former CEO and Chairman of Newstrike Brands Ltd.—one of Canada's first licensed cannabis p
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-10-30 9:00 AM EDT | Herbal Dispatch Inc.
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has executed a definitive securities exchange agreement (the "Definitive Agreement") with Canurta Limited Partnership ("Canurta") and each of the limited partners of Canurta, the parent en
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-10-30 9:00 AM EDT | PharmaDrug Inc.
Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc.
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Inc. (CSE: DCNN) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that on October 22, 2025 it entered into a Termination, Settlement and Release Agreement (the "Settlement Agreement") with 3Win Corp. ("3Win") and D-3 Merger Sub, Inc. to mutually terminate the Business Combination Agreement dated September 27
Banking / Financial Services, Cannabis
2025-10-29 4:30 PM EDT | Digicann Ventures Inc.
Flora Growth Corp. Announces Second Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Fort Lauderdale, Florida--(Newsfile Corp. - October 21, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G"), today announced the purchase of 880,025 $0G at an average price of $2.27. The purchase represents the Company's second acquisition of $0G since its most recent
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-10-21 8:00 AM EDT | Flora Growth Corp.
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025. Next-generation therapy CR
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-10-21 7:27 AM EDT | Cardiol Therapeutics Inc.
Akanda Corp. Increasing Its Cannabis Investment
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation license for a variety of potential products containing THC, but currently it is operating under its hemp cultivation license. A further extension of the license
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-20 8:00 AM EDT | Akanda Corp
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025. Next-generation therapy CR
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-10-17 4:34 PM EDT | Cardiol Therapeutics Inc.
Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today a major network expansion initiative with the construction of new cellular towers within the proximity of its existing tower network. The Company plans to construct and/or acquire up to 20 new or existing towers/sites by the end of
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-16 4:15 PM EDT | Akanda Corp
Flora Growth Corp. Appoints BitGo as Custodian for $0G Treasury
Fort Lauderdale, Florida--(Newsfile Corp. - October 16, 2025) - Flora Growth Corp. (NASDAQ: FLGC), which is set to rebrand as ZeroStack (the "Company"), the first and largest decentralized AI treasury company, has appointed BitGo Trust Company, Inc. ("BitGo") to provide institutional-grade custody for the Company's $0G treasury. BitGo, the digital asset infrastructure company, has enabled its clients to securely navigate the digital asset space since 2013 by delivering custody, wallets,
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-10-16 8:00 AM EDT | Flora Growth Corp.
Adastra Holdings Announces Completion of Sale of Subsidiaries
Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("1178562"), and Adastra Brands Inc. ("Adastra Brands"), to 1538634 B.C. Ltd. (the "Purchaser
2025-10-15 6:57 PM EDT | Adastra Holdings Ltd.
City View Announces ArkenYield Partnership with Unique Digital Assets Ltd. to Manage up to $500M for Institutional Depositors
Toronto, Ontario--(Newsfile Corp. - October 15, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that, investee company ArkenYield Ltd. ("ArkenYield"), has recently entered into a strategic partnership with Unique Digital Assets Ltd. ("UDA"), a licensed and regulated financial service provider specializing in digital asset custody OTC trading, payment and yield solutions. Pursuant to the partnership, ArkenYie
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2025-10-15 6:00 AM EDT | City View Green Holdings Inc.
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-10-14 8:34 AM EDT | Red Light Holland Corp.
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its growing portfolio, developed to support female fertility and reproductive function in women of advanced maternal age (35+). CBIH believes this innovation should expand evidence-based options for patients and partners. As age is a key determinant of reproductive outcomes—and first births
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-10-13 7:00 AM EDT | Cannabis Bioscience International Holdings
Akanda Corp. Addresses Impacts of Postal Strike on Receiving Materials for Its Upcoming Special Meeting
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that, due to the ongoing postal strike in Canada, the Company is unable to mail shareholder proxy materials (the "Meeting Materials") for its upcoming special meeting (the "Meeting") of shareholders scheduled for 10:00 a.m. (Toronto time) on Thursday, October 30, 2025, at the offices of Gowling WLG (Canada) LLP, Suite 1600, 100
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-10 2:00 PM EDT | Akanda Corp
Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing
Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG0) ("GHG" or the "Company") announces that it has applied to the British Columbia Securities Commission ("BCSC") for a partial revocation order (the "Partial Revocation Order") in connection with the failure-to-file cease trade order ("FFCTO") issued against the Company on April 15, 2025, for failing to file certain continu
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Cannabis
2025-10-09 9:29 AM EDT | Global Hemp Group Inc.
Psyched Wellness Provides Comprehensive Investor Update
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide the following corporate update to its investors. Product Development & Launches Santa - Dietary Supplement Shot Following the initia
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2025-10-09 7:30 AM EDT | Psyched Wellness Ltd.
Adastra Holdings Enters into Agreements to Sell Subsidiaries
Langley, British Columbia--(Newsfile Corp. - October 8, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has entered into agreements to sell all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("1178562"), and Adastra Brands Inc. ("Adastra Brands"). The aggregate consideration for all transactions is $4,000,000,
2025-10-08 11:28 PM EDT | Adastra Holdings Ltd.
Flora Growth Corp. Announces First Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Fort Lauderdale, Florida--(Newsfile Corp. - October 8, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G"), today announced the purchase of 772,200 0G at an average price of $2.59. The purchase represents the Company's first acquisition of 0G since its most recent $40
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-10-08 8:00 AM EDT | Flora Growth Corp.
Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025
Dream Water® USA and Dream Water® Canada achieve double digit revenue growth in e-commerce and retail channels LivRelief™ Canada achieves double-digit revenue growth in ecommerce Strong Dream Water and LivRelief results partially offset by reduced revenues in LivRelief Infused business. Management implementing new route-to-market strategy to recapture growth
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-10-06 7:30 AM EDT | Delivra Health Brands Inc.
Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook
Houston, Texas--(Newsfile Corp. - October 6, 2025) - Cannabis Bioscience International Holdings, Inc., (OTCID: CBIH), a publicly traded biomedical cannabis research and development company listed on the OTC Markets under the ticker symbol CBIH, today announced the appointment of Mr. Andy Trivedi, MBA, to its Board of Directors. The addition of Mr. Trivedi marks a strategic step forward in the Company's mission to scale operations, expand access to capital, and enhance long-term shareholder va
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-10-06 7:00 AM EDT | Cannabis Bioscience International Holdings